ROYAL OAK -- Over the past two decades, cardiologists have explored many different treatments to help prevent permanent heart damage after a heart attack. One treatment that appears to be very ...

Results of a clinical trial demonstrate that an infusion of blood that is "supersaturated" with oxygen (SS02) can reduce the amount of damaged heart muscle immediately following a life-threatening ...

SAN DIEGO - A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) ...

Newark Beth Israel Medical Center, an RWJBarnabas Health facility, now offers heart attack patients a minimally invasive, “cutting-edge” cardiac treatment. The health care provider announced Nov. 29 ...

IRVINE, Calif.--(BUSINESS WIRE)--TherOx, a ZOLL ® Medical company, announces key data presentations and company-sponsored events for SuperSaturated Oxygen (SSO 2) Therapy at the upcoming Transcatheter ...

A physician at the Prebys Cardiovascular Institute in La Jolla is taking part in a nationwide clinical trial of a technique that uses supersaturated oxygen to reduce tissue damage suffered by heart ...

The Prebys Cardiovascular Institute in La Jolla is taking part in a nationwide clinical trial of a technique that uses supersaturated oxygen to reduce tissue damage suffered by heart attack patients, ...

HORIZON AMI: Results. Baseline clinical characteristics are shown in the following Table. A total of 93% of patients underwent PCI. The primary endpoint of the study -- net clinical outcomes and major ...

TherOx, an Irvine, Calif.-based medical device company, seeks $25 million for the final push to bring its treatment to increase the quality of life for heart attack patients. The company’s optimized ...

IRVINE, Calif.--(BUSINESS WIRE)--TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced it has received U.S. Food and Drug ...

CHELMSFORD, Mass., October 31, 2022--(BUSINESS WIRE)--ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that its TherOx SuperSaturated ...